Women with Autoimmune Diseases Face Higher Cardiovascular Death Risk

A comprehensive study published in the American Heart Association's journal Circulation: Cardiovascular Quality and Outcomes has uncovered stark gender differences in cardiovascular disease-related deaths among individuals with autoimmune diseases. Researchers analyzed data from over 281,000 deaths associated with rheumatoid arthritis, lupus, and systemic sclerosis between 1999 and 2020.

The study found that while overall cardiovascular disease-related deaths declined during this period, women consistently experienced higher mortality rates. Women with these autoimmune conditions had a 50% higher cardiovascular disease-related death rate compared to men, with the disparity most pronounced in rheumatoid arthritis patients.

Key findings revealed that women were more than twice as likely to die from arrhythmia or cardiac arrest. Stroke and coronary artery disease emerged as the primary causes of cardiovascular deaths, with women experiencing higher rates in both categories. The cardiovascular disease-related death rate for women with rheumatoid arthritis was approximately three times higher than for men.

These findings are particularly significant given that women are already two to three times more likely to develop rheumatoid arthritis and approximately nine times more likely to have lupus. The study underscores the critical need for targeted cardiovascular screening and prevention strategies for women with immune-mediated inflammatory diseases.

Dr. Heba S. Wassif, senior study author, emphasized the importance of early screening and addressing cardiovascular risk factors at the time of diagnosis. The research highlights a critical gap in understanding and managing cardiovascular risks for women with autoimmune conditions, pointing to the necessity of further investigation into the underlying causes of these gender disparities.